open-label BE trials maintain blindness [Study Per­for­mance]

posted by ElMaestro  – Denmark, 2023-10-14 19:39 (598 d 18:24 ago) – Posting: # 23755
Views: 4,597

Hi kimhaung,

❝ How do open-label BE trials maintain blindness until the database is locked?


I had a small coughing fit reading this line :-)

Can I ask:
  1. Who do you want to keep blind and why? Monitor, PI, bioanalytical staff, QA, sponsor, PK staff, statistics staff, pharmacy staff, clinical staff etc?
  2. Are the people who create the rand. code also the people who do NCA? is it the same people who do stats?
  3. Who has access to the rand. code? I do not mean who should have access.
  4. Do some of the staff with access to the rand. code also undertake other functions by any chance?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,682 registered users;
50 visitors (0 registered, 50 guests [including 11 identified bots]).
Forum time: 14:04 CEST (Europe/Vienna)

Pharmacokinetics: one of the magic arts of divination
whereby needles are stuck into dummies in an attempt
to predict profits.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5